Scaling up and scaling out: pushing the boundaries of transient protein production

While transient yields have improved drastically in the last decade, scalable systems are time-consuming and costly to implement. Absolute Antibody has developed systems which scale up and scale out protein expression and purification, enabling the rapid and cost-effective production of milligram-to-gram quantities of large panels of proteins.

In this presentation, our CSO Dr. Ian Wilkinson describes the different systems Absolute Antibody has developed to optimize transient antibody production. We use this transient expression system to offer royalty-free antibody manufacturing services, as well as a unique reagents catalog of engineered recombinant antibodies. Please enter your information below to view the video.

Absolute Antibody may use your contact information to send you information about our products and services. You can unsubscribe at any time by clicking the “unsubscribe” link included in every marketing email. For more information, please see our privacy policy here.